[go: up one dir, main page]

WO2002062982A1 - Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications - Google Patents

Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications Download PDF

Info

Publication number
WO2002062982A1
WO2002062982A1 PCT/CN2001/000115 CN0100115W WO02062982A1 WO 2002062982 A1 WO2002062982 A1 WO 2002062982A1 CN 0100115 W CN0100115 W CN 0100115W WO 02062982 A1 WO02062982 A1 WO 02062982A1
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
gene
cell immune
specific
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000115
Other languages
English (en)
Chinese (zh)
Inventor
Kamfu Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIX FOREST BIO-SCIENCE INSTITUTE Ltd
Original Assignee
SIX FOREST BIO-SCIENCE INSTITUTE Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIX FOREST BIO-SCIENCE INSTITUTE Ltd filed Critical SIX FOREST BIO-SCIENCE INSTITUTE Ltd
Priority to PCT/CN2001/000115 priority Critical patent/WO2002062982A1/fr
Publication of WO2002062982A1 publication Critical patent/WO2002062982A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Landscapes

  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention porte sur un procédé faisant appel à des informations relatives à des ondes bioélectriques de simulation consistant à activer un gène récessif de levure normale et à la transformer en levure spécifique, les protéines spécifiques (enzymes) exprimées par la levure spécifique présentant la fonction d'activation, de régulation et de correction de gènes immunitaires de lymphocytes B, de gènes immunitaires de lymphocytes T, de gènes immunitaires de lymphocytes K et de gènes allèles de lymphocytes NK à faible compétence immunologique. La levure spécifique sous forme de préparation biologique permet de réguler le gène immunitaire du corps afin de rétablir les fonctions immunitaires du corps et de soigner le patient. Les préparations biologiques peuvent être appliquées dans le traitement de différentes maladies, notamment les tumeurs, l'urémie, l'hépatite, la démence sénile, les maladies gastro-intestinales, le diabète, et les troubles du système nerveux. Cette préparation est très efficace, sans effets toxiques ou secondaires.
PCT/CN2001/000115 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications Ceased WO2002062982A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000115 WO2002062982A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000115 WO2002062982A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications

Publications (1)

Publication Number Publication Date
WO2002062982A1 true WO2002062982A1 (fr) 2002-08-15

Family

ID=4574769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000115 Ceased WO2002062982A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications

Country Status (1)

Country Link
WO (1) WO2002062982A1 (fr)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour des sujets infectés par le VIH
EP1375651A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour l'activation et la prolifération des globules blancs
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US6964864B2 (en) 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US6979562B2 (en) 2003-11-18 2005-12-27 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7078202B2 (en) 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7259001B2 (en) 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US7297522B2 (en) 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy
WO2011023769A1 (fr) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition destinée au traitement de maladies ou de troubles neurodégénératifs, méthode et utilisation impliquant de la levure électromagnétiquement irradiée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09182582A (ja) * 1996-01-05 1997-07-15 Kagaku Gijutsu Shinko Jigyodan 細胞培養法と細胞培養装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09182582A (ja) * 1996-01-05 1997-07-15 Kagaku Gijutsu Shinko Jigyodan 細胞培養法と細胞培養装置

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DING ZHISHAN ET AL.: "Transforming yeast bioplast by ultrasonic-method", BIOTECHNOLOGY, vol. 6, no. 4, 1996, pages 41 - 43 *
GAO DAWEI ET AL.: "Effects of linear ultrasonic wave irradiation on the growth of saccharomyces cerevisiae", JOURNAL OF SOUTH CHINA UNIVERSITY OF TECHNOLOGY (NATURAL SCIENCE), vol. 27, no. 12, December 1999 (1999-12-01), pages 34 - 37 *

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour des sujets infectés par le VIH
EP1375651A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour l'activation et la prolifération des globules blancs
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7172888B2 (en) 2003-06-11 2007-02-06 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7163813B2 (en) 2003-06-11 2007-01-16 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7172889B2 (en) 2003-06-11 2007-02-06 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7078202B2 (en) 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US7208159B2 (en) 2003-11-18 2007-04-24 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6979562B2 (en) 2003-11-18 2005-12-27 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US6964864B2 (en) 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US7259001B2 (en) 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US7297522B2 (en) 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy
WO2011023769A1 (fr) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition destinée au traitement de maladies ou de troubles neurodégénératifs, méthode et utilisation impliquant de la levure électromagnétiquement irradiée
CN102481368A (zh) * 2009-08-26 2012-05-30 密美德有限公司 包含电磁辐射的酵母的治疗神经变性疾病或病症的组合物、方法和用途
JP2013503138A (ja) * 2009-08-26 2013-01-31 エムビー ミルメド エービー 電磁放射酵母を含む神経変性疾患または障害の処置のための組成物、方法および使用
CN102481368B (zh) * 2009-08-26 2014-01-29 密美德有限公司 包含电磁辐射的酵母的治疗神经变性疾病或病症的组合物、方法和用途
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
WO2002062982A1 (fr) Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2002062984A1 (fr) Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications
WO2002062985A1 (fr) Levure faisant preuve d'un activite immunoregulatrice cellulaire nk, son procede de preparation et ses applications
WO2002062981A1 (fr) Immunoregulateur humain de levure et son procede de preparation
WO2002062983A1 (fr) Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2005049593A3 (fr) Promoteurs de l'apoptose contenant n-acylsulfonamide
WO2004047728A3 (fr) Compositions et procedes destines au traitement de maladies de nature immune
WO2004039956A3 (fr) Compositions et methodes de traitement de maladies liees au systeme immunitaire
WO2004110472A3 (fr) Proteines de fusion
WO2005037257A3 (fr) Nouveaux inhibiteurs d'alanyl-aminopeptidases destines a exercer une influence fonctionnelle sur diverses cellules et a constituer un traitement immunologique de maladies inflammatoires, neuronales et autres
AU3642499A (en) Ste20-related protein kinases
WO2005016947A3 (fr) Modulation antisens de l'expression de la kinase proteine activee par le mitogene p38
WO2005058945A3 (fr) Variants genetiques codant pour des proteines issues de la voie metabolique de produits chimiques fins
AU2003228530A1 (en) Use of parapox b2l protein to modify immune responses to administered antigens
WO2004024072A3 (fr) Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire
WO2007092609A3 (fr) Procede de traitement de maladie arterielle peripherique par proteines a doigts de zinc
WO2002101068A3 (fr) Procede de preparation de l'acide d-pantothenique et/ou de ses sels
AU2002358488A1 (en) Alleles of the glucokinase gene coryneform bacteria
WO2003006630A3 (fr) Preparations fantomes exemptes d'acides nucleiques
WO2004072263A3 (fr) Acide nucleique et proteine correspondante dite 158p1d7, utiles pour le traitement et la detection de cancers de la vessie et autres
WO2005113017A3 (fr) Therapie genique a base de gfap pour le traitement des maladies de la retine
WO2003038035A3 (fr) Enzymes phytase produites par trichoderma reesei, acides nucleiques codant les enzymes phytase, vecteurs et cellules hotes incorporant les enzymes phytase, et methodes de production et d'utilisation des enzymes phytase
WO2003022883A3 (fr) Utilisation d'une proteine pour preparer un medicament servant a stimuler le systeme immunitaire inne non specifique
WO2002022631A3 (fr) Regulation d'une enzyme de type pyroglutamyl peptidase humaine
WO2005023979A3 (fr) Molecules d'acide nucleique de s. mansoni isolees et utilisations associees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP